Deciphering the Logic of Natural Product Biosynthesis

Bo Li
DOI: https://doi.org/10.1096/fasebj.31.1_supplement.607.9
2017-04-01
The FASEB Journal
Abstract:Natural products and derivatives constitute a large fraction of modern medicine, especially in the arena of antimicrobial therapy. To identify and engineer new natural products, it is critical to understand the mechanisms of chemical transformations responsible for biosynthesis. My group seeks to characterize the novel enzyme chemistries in the construction of biosynthetic building blocks and those that assemble these building blocks into complex and potent natural products. In this talk, I will discuss our work on the biosynthesis of thiomarinol that is a naturally occurring hybrid antibiotic between two antimicrobial “warheads”, pseudomonic acid and holothin, linked by an amide bond. We investigated the enzyme basis of “hybridity” in thiomarinol biosynthesis (1). Contrary to the previous proposal, we showed that a CoA ligase and an acyltransferase act in tandem to catalyze the amidation step. We also studied the substrate scope of this enzyme pair in vitro and demonstrated that these enzymes can incorporate non‐native functional groups into thiomarinol analogs. Our results revealed important insight regarding convergent evolution and uncovered a useful strategy to create new “hybrid” molecules. I will also discuss our ongoing efforts on the biosynthesis of nonproteinogenic amino acids, important building blocks for natural product biosynthesis. Mechanistic insights gained from our research will enable identification and engineering of natural products as potential drug leads.
What problem does this paper attempt to address?